Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma. [electronic resource]
Producer: 20091211Description: 689-92 p. digitalISSN:- 1432-069X
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antigens, Neoplasm -- metabolism
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Doxorubicin -- therapeutic use
- Humans
- Immunotherapy
- Injections, Intravenous
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Male
- Prednisone -- therapeutic use
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Rituximab
- Skin Neoplasms -- diagnosis
- Treatment Outcome
- Vesicular Transport Proteins -- metabolism
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.